Literature DB >> 7294735

Computerized tomography in subacute necrotizing encephalomyelopathy (Leigh disease).

W J Schwartz, H T Hutchison, B O Berg.   

Abstract

Entities:  

Mesh：

Year:  1981        PMID： 7294735     DOI： 10.1002/ana.410100313

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  8 in total

1.  Bilateral striatal necrosis, dystonia and optic atrophy in two siblings.

Authors:  V Leuzzi; E Bertini; A M De Negri; M Gallucci; B Garavaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

2.  Adult form of Leigh's disease: a clinico pathological case with CT scan examination.

Authors:  F Gray; F Louarn; R Gherardi; J F Eizenbaum; C Marsault
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

3.  Glutaric aciduria type I. Brain CT features and a diagnostic pitfall.

Authors:  H Mandel; J Braun; O el-Peleg; E Christensen; M Berant
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 4.  Ataxic variant of adrenoleukodystrophy: MRI and CT findings.

Authors:  H Kusaka; T Imai
Journal:  J Neurol       Date:  1992-07       Impact factor: 4.849

5.  Bilateral paramedian thalamic infarctions: a CT study.

Authors:  O Gerber; M Gudesblatt
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

6.  Familial dystonia and visual failure with striatal CT lucencies.

Authors:  C D Marsden; A E Lang; N P Quinn; W I McDonald; A Abdallat; S Nimri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

7.  Necrotising haemorrhagic encephalomyelopathy in an adult: Leigh's disease.

Authors:  G Delgado; J Gállego; T Tuñón; J J Zarranz; J A Villanueva
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

8.  X-linked Leigh's syndrome.

Authors:  P J Benke; J C Parker; M L Lubs; J Benkendorf; A E Feuer
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.